Ownership of Common Stock. As of the date hereof, Intrexon (8,675,768) and its Affiliates (NRM VII Holdings, LLC - 3,625,000) beneficially own 12,300,768 shares of Common Stock of the Company.
Appears in 2 contracts
Samples: Stock Issuance Agreement, Stock Issuance Agreement (Synthetic Biologics, Inc.)
Ownership of Common Stock. As of the date hereof, excluding the Private Placement Shares and Technology Access Fee Shares, Intrexon (8,675,768) and its Affiliates beneficially own 5,249,980 (Intrexon-4,392,425/NRM VII HoldingsHoldings I, LLC - 3,625,000LLC-857,555) beneficially own 12,300,768 shares of Common Stock of the Company.
Appears in 2 contracts
Samples: Stock Purchase and Issuance Agreement (Oragenics Inc), Stock Purchase and Issuance Agreement (Intrexon Corp)
Ownership of Common Stock. As of the date hereof, Intrexon (8,675,768) and its Affiliates affiliates beneficially own 9,839,221 shares (Intrexon - 8,838,666 shares, NRM VII HoldingsHoldings I, LLC - 3,625,0001,000,555 shares) beneficially own 12,300,768 shares of Common Stock of the Company.
Appears in 1 contract
